Skip to main content
# Title Department Research Year
51 Sertaconazole-PLGA nanoparticles for management of ocular keratitis Department of Pharmaceutics 2024
52 Design, synthesis, and antiproliferative activity of new 1,2,3-Triazole/Quinazoline-4-one hybrids as dual EGFR/BRAFV600E inhibitors Department of Pharmaceutical Organic Chemistry 2024
53 Design, synthesis, biological evaluation and docking study of some new aryl and heteroaryl thiomannosides as FimH antagonists Department of Pharmaceutical Organic Chemistry 2024
54 A surfactant-based quasi-hydrophobic deep eutectic solvent for dispersive liquid-liquid microextraction of gliflozins from environmental water samples using UHPLC/fluorescence detection Department of Pharmaceutical Analytical Chemistry 2024
55 New diaryl-1,2,4-triazolo[3,4-a]pyrimidine hybrids as selective COX-2/sEH dual inhibitors with potent analgesic/anti-inflammatory and cardioprotective properties Department of Pharmaceutical Organic Chemistry 2024
56 Evaluating anthelmintic, anti‑platelet, and anti‑coagulant activities, and identifying the bioactive phytochemicals of Amaranthus blitum L. Department of Pharmacognosy 2024
57 Design and synthesis of new 1,2,4-oxadiazole/quinazoline-4-one hybrids with antiproliferative activity as multitargeted inhibitors Department of Pharmaceutical Organic Chemistry 2024
58 Tetrahydro-(2H)-1,3,5-thiadiazine-2-thione (THTT), A Versatile Carrier System for Targeting Cell Cycle Checkpoint Pathways with Potential Anticancer Activities Department of Medicinal Chemistry 2024
59 Mesenchymal stem cell therapy in diabetic foot ulcer: An updated comprehensive review Department of Microbiology and Immunology 2024
60 Design and synthesis of new 1, 2, 4-oxadiazole/quinazoline-4-one hybrids with antiproliferative activity as multitargeted inhibitors Department of Pharmaceutical Organic Chemistry 2024